Advertisement: Bradfield Centre mid
Mid banner advertisement: BDO
Advertisement: Cambridge Network
ARM Innovation Hub
Advertisement: Wild Knight Vodka
Advertisement: TTP
RealVNC mid banner careers
Advertisement EY mid banner
Advertisement: RSM
Advertisement: Mogrify mid banner
RealVNC mid-banner general
Advertisement Cambridge China Centre
Barr Ellison Solicitors – commercial property
15 February, 2019 - 11:55 By Kate Sweeney

Jackson awarded top European cancer research prize

Cambridge research doyen Professor Steve Jackson has won a major European prize for cancer research.

Professor Jackson is to receive the ARC Foundation’s Léopold Griffuel Award, worth €150k, in Paris this April.

He is senior group leader and head of Cancer Research UK laboratories at the Wellcome/Cancer Research UK Gurdon Institute; Frederick James Quick Professor of Biology (associated with St John’s College) and member of the Department of Biochemistry.

The coveted European cancer research prize has been awarded annually since 1970.

Fondation ARC is the largest French foundation dedicated entirely to cancer research and is funded by public donations. Its mission is to support research in the fight to eradicate cancers, with an ambitious goal “to cure two cancers out of three by 2025.”

The award winners are scientists and physicians who have made an important contribution to better understand, diagnose, cure and prevent cancers. 

Professor Jackson is honoured for his work in translational and clinical research, principally on DNA damage repair and his role in the development of medicines such as PARP1 and 2 inhibitors, currently used for cancer treatment. Professor Jackson said: “I am deeply honoured and delighted to be given this prestigious award for my research, which has been translated into patient benefit.

“The field of DNA damage repair has expanded substantially in recent years and continues to provide us with new avenues for understanding the causes of cancer, and identifying new therapeutic targets.”

• The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development and how normal growth and maintenance go wrong in cancer and other diseases.

Add new comment

Newsletter Subscription

Stay informed of the latest news and features